SIGA Technologies, Inc. (SIGA)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$3.29+1.86%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · SIGA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 53.7 | 94.6 | 138.7 | 139.9 | 110.8 | 133.7 | 125.0 | 26.7 | 477.1 | — | — | — | — | — | — | — |
| Cost of Revenues | 24.5 | 29.7 | 31.3 | 17.8 | 10.4 | 16.6 | 14.8 | 1.8 | 95.3 | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 19.9 | 21.2 | 25.1 | 22.0 | 35.1 | 18.0 | 14.7 | 13.3 | 12.9 | 12.3 | 13.7 | 10.6 | 12.6 | 13.1 | 11.0 | 23.9 |
| R&D Expenses | 20.4 | 20.0 | 12.3 | 16.4 | 22.5 | 9.9 | 10.9 | 13.3 | 13.0 | 16.7 | 19.7 | 13.1 | 10.7 | 13.8 | 18.2 | 18.4 |
| Operating Income | (11.1) | 23.7 | 70.0 | 83.6 | 42.7 | 89.1 | 84.5 | (2.3) | 355.1 | (18.8) | (31.0) | (31.0) | (209.7) | (23.5) | (22.5) | (31.4) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | 0.0 | 0.0 | 3.0 | 15.8 | 15.5 | 14.8 | 2.4 | 0.3 | 0.5 | 1.2 | 0.2 | — |
| Other Non-Operating Income / Expenses | 5.6 | 6.7 | 6.1 | 4.2 | 1.0 | 0.1 | 0.5 | 2.8 | 78.9 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | (5.5) | 30.4 | 76.1 | 87.8 | 44.1 | 89.3 | 73.5 | (10.2) | 411.6 | (38.3) | (39.7) | (39.0) | (211.9) | (24.8) | (21.9) | (6.9) |
| Income Tax Expense | (2.7) | 7.1 | 16.9 | 19.7 | 10.2 | 19.9 | 17.2 | (2.9) | (10.2) | (2.1) | 0.0 | 0.5 | 53.5 | (7.6) | (7.8) | (36.0) |
| Net Income | ||||||||||||||||
| Net Income | (2.8) | 23.3 | 59.2 | 68.1 | 33.9 | 69.5 | 56.3 | (7.2) | 421.8 | (36.2) | (39.7) | (39.5) | (265.5) | (17.2) | (14.1) | 29.1 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.04) | 0.33 | 0.83 | 0.95 | 0.46 | 0.92 | 0.71 | (0.09) | 5.28 | — | — | (0.73) | (4.97) | (0.33) | (0.27) | 0.57 |
| Diluted EPS | (0.04) | 0.32 | 0.82 | 0.95 | 0.46 | 0.91 | 0.71 | (0.15) | 5.18 | — | — | (0.73) | (4.97) | (0.33) | (0.27) | 0.09 |
| Revenue per Share | 0.75 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 71.8 | 71.5 | 71.3 | 71.4 | 72.9 | 75.3 | 79.3 | 81.0 | 79.9 | — | — | 53.8 | 53.4 | 52.4 | 51.6 | 50.9 |
| Diluted Weighted Avg Shares | 71.9 | 71.9 | 71.9 | 71.7 | 73.5 | 76.4 | 79.4 | 82.2 | 82.7 | — | — | 53.8 | 53.4 | 52.4 | 51.6 | 54.1 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 24.3 | 70.5 | 84.2 | 43.2 | 89.6 | 85.0 | (1.8) | 355.2 | (18.7) | (30.8) | (30.7) | (209.3) | (23.1) | (22.1) | (30.8) |
| EBIT | (11.1) | 23.7 | 70.0 | 83.6 | 42.7 | 89.1 | 84.5 | (2.3) | 355.1 | (18.8) | (31.0) | (31.0) | (209.7) | (23.5) | (22.5) | (31.4) |
| Effective Tax Rate | 49.4% | — | — | 22.5% | 23.2% | 22.2% | 23.4% | 28.9% | -2.5% | 5.5% | -0.0% | -1.2% | -25.3% | 30.7% | 35.8% | 519.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.